Meriem Messaoudene

机构：Centre Hospitalier de l’Université de Montréal · ORCID：0000-0002-6805-3315

发表论文 18 篇 · 总被引 417 次 · h-index 7

代表论文

• Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome (2024 · Cell · 被引 189)
• The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development (2025 · Nature Reviews Drug Discovery · 被引 77)
• Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial (2026 · Nature Medicine · 被引 61)
• Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance (2024 · Molecular Cancer · 被引 26)
• Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France (2020 · Journal of Geriatric Oncology · 被引 23)
• Benzodiazepines compromise the outcome of cancer immunotherapy (2024 · OncoImmunology · 被引 17)